pioneer 5 semaglutide exposure is dose proportionate in the and SUSTAIN The development of oral semaglutide,

290 , H1729H1739 (2006)

Patients should contact their GP or healthcare provider urgently if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Difficulty swallowing or painful swallowing Unexplained weight loss Vomiting blood or passing black stools (seek immediate emergency care) Note that the 3 mg dose of Rybelsus is only for treatment initiation (30 days), and dose escalation to 7 mg (and later 14 mg if needed) can be delayed if gastrointestinal side effects persist

Pickart L, Margolina A

MORPH X5 (20 Serve - Frosted Cherry)